121 related articles for article (PubMed ID: 8804146)
1. A bivariate parametric model for survival and intermediate event times.
Epstein LD; Muñoz A
Stat Med; 1996 Jun; 15(11):1171-85. PubMed ID: 8804146
[TBL] [Abstract][Full Text] [Related]
2. Local likelihood analysis of the latency distribution with interval censored intermediate events.
Bebchuk JD; Betensky RA
Stat Med; 2002 Nov; 21(22):3475-91. PubMed ID: 12407685
[TBL] [Abstract][Full Text] [Related]
3. The association between cigarette smoking and selected HIV-related medical conditions.
Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
[TBL] [Abstract][Full Text] [Related]
4. Partly conditional survival models for longitudinal data.
Zheng Y; Heagerty PJ
Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
[TBL] [Abstract][Full Text] [Related]
5. A competing risks analysis of presenting AIDS diagnoses trends.
Fusaro RE; Bacchetti P; Jewell NP
Biometrics; 1996 Mar; 52(1):211-25. PubMed ID: 8934593
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
[TBL] [Abstract][Full Text] [Related]
9. [The concept of risk and its estimation].
Zocchetti C; Della Foglia M; Colombi A
Med Lav; 1996; 87(4):330-47. PubMed ID: 9102559
[TBL] [Abstract][Full Text] [Related]
10. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
11. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
[TBL] [Abstract][Full Text] [Related]
12. [Factors associated with survival in Kaposi's sarcoma in patients infected with the human immunodeficiency virus. Clinical Epidemiological Group for AIDS in Aquitaine].
Cazorla C; Dabis F; Dupon M; Ragnaud JM; Geniaux M; Pellegrin JL; Salmi LR
Rev Epidemiol Sante Publique; 1999 Apr; 47(2):109-17. PubMed ID: 10367298
[TBL] [Abstract][Full Text] [Related]
13. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
Bebchuk JD; Betensky RA
Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
[TBL] [Abstract][Full Text] [Related]
15. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma.
Gorsky M; Epstein JB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):612-7. PubMed ID: 11077385
[TBL] [Abstract][Full Text] [Related]
16. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma: an update.
Schwartz RA
J Surg Oncol; 2004 Sep; 87(3):146-51. PubMed ID: 15334644
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
20. The generalized F distribution: an umbrella for parametric survival analysis.
Cox C
Stat Med; 2008 Sep; 27(21):4301-12. PubMed ID: 18407568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
